Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals Sees FY Revenue USD 375-385 Million

Jun 1 (Reuters) - Catalyst Pharmaceuticals Outlook FY adjusted net income USD
195-205 million.
* Outlook FY revenue USD 375-385 million

Recent news on Catalyst Pharmaceuticals

See all news